EGFR and neoplasm: Here, we demonstrated the feasibility and potential diagnostic value of circulating miR-504 expression in plasma to discriminate between EGFR-mutated and EGFR wild-type NSCLC, and also between EGFR-mutated and KRAS-mutated tumours.